SAN FRANCISCO, Dec. 3, 2019 /PRNewswire/ — The global smart biopsy device market size is anticipated to reach USD 3.72 billion by 2026, registering a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive biopsy procedure coupled with technological advancements in smart biopsy device is anticipated to boost the growth.

Read the 171 pages research report with ToC on “Smart Biopsy Devices Market Size, Share & Trends Analysis Report By Application (Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer), By Region, And Segment Forecasts, 2019 – 2026” at: https://www.grandviewresearch.com/industry-analysis/smart-biopsy-devices-market

Minimally Invasive Breast Biopsy Technique (MIBT) allows diagnosis of breast cancer without taking patient to surgery, preserves normal breast tissue, and decreases the number of operations required for cancer treatment. In addition, technological advancements in MIBT, such as needle-based biopsy guns to obtain cells, core needles biopsy to obtain sample tissue, specialized biopsy device that utilize vacuum and cutting device to remove sample tissues. Thus, minimally invasive procedures such as MIBT are recommended more as compared to conventional biopsy methods due to minimal risk factor. This is projected to drive the market for smart biopsy devices in near future.

Siemens Healthineers mammography system enables healthcare providers to improve their biopsy workflow as it uses 3D HD biopsy to obtain effective biopsies at a lower dose. It also offers automated breast density measurement with titanium enhanced mammography exams. Such technological advancements have improved biopsy procedure workflow by reducing morbidity. They have also increased patient satisfaction which is expected to bode well for the growth of the market.

Grand View Research has segmented the global smart biopsy device market based on application and region:

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:Sherry JamesCorporate Sales Specialist, USAGrand View Research, Inc.Phone: +1-415-349-0058Toll Free: 1-888-202-9519Email: [email protected] Web: https://www.grandviewresearch.com Follow Us: LinkedIn | Twitter

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update Summary of an Actuarial Analysis and Report

Editorial: Peter Wehrwein, EditorAdvertising: Maureen Dwyer Liberti, Vice President, Group PublisherGreg Pessagno, National Account ManagerAmy Birnbach, National Account ManagerProduction: Dawn Flook, Director of Production ServicesWebmaster: Webmaster

Terms and Conditions for Using this Site © 2019 MediMedia, an ICON plc company. All Rights Reserved.